{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:44:58Z","timestamp":1790081098713,"version":"4.0.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA037820"],"award-info":[{"award-number":["DA037820"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>West Virginia is a largely rural state with strong ties of kinship, mutual systems of support and charitable giving. At the same time, wealth inequalities are extreme and the state\u2019s drug overdose fatality rate stands above all others in the USA at 51.5\/100,000 in 2018, largely opioid-related. In recent years, harm reduction services have been active in the state but in 2018 Charleston\u2019s needle and syringe program was forced to close. This paper considers the risk environment in which the state\u2019s drug-related loss of life, and those attempting to prevent it, exist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This rapid ethnographic study involved semi-structured interviews (n\u2009=\u200921), observation and video recordings of injection sequences (n\u2009=\u20095), initially recruiting people who inject heroin\/fentanyl (PWIH) at the Charleston needle and syringe program. Snowball sampling led the research team to surrounding towns in southern West Virginia. Telephone interviews (n\u2009=\u20092) with individuals involved in service provision were also carried out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PWIH in southern West Virginia described an often unsupportive, at times hostile risk environment that may increase the risk of overdose fatalities. Negative experiences, including from some emergency responders, and fears of punitive legal consequences from calling these services may deter PWIH from seeking essential help. Compassion fatigue and burnout may play a part in this, along with resentment regarding high demands placed by the overdose crisis on impoverished state resources. We also found low levels of knowledge about safe injection practices among PWIH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hostility faced by PWIH may increase their risk of overdose fatalities, injection-related injury and the risk of HIV and hepatitis C transmission by deterring help-seeking and limiting the range of harm reduction services provided locally. Greater provision of overdose prevention education and naloxone for peer distribution could help PWIH to reverse overdoses while alleviating the burden on emergency services. Although essential for reducing mortality, measures that address drug use alone are not enough to safeguard longer-term public health. The new wave of psychostimulant-related deaths underline the urgency of addressing the deeper causes that feed high-risk patterns of drug use beyond drugs and drug use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-020-00416-w","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:02:41Z","timestamp":1602489761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hostility, compassion and role reversal in West Virginia\u2019s long opioid overdose emergency"],"prefix":"10.1186","volume":"17","author":[{"given":"Jeff","family":"Ondocsin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7109-8602","authenticated-orcid":false,"given":"Sarah G.","family":"Mars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ciccarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"issue":"5152","key":"416_CR1","first-page":"1419","volume":"67","author":"L Scholl","year":"2019","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths-United States, 2013\u20132017. MMWR Morb Mortal Wkly Rep. 2019;67(5152):1419\u201327.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"416_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","volume":"67","author":"P Seth","year":"2018","unstructured":"Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants-United States, 2015\u20132016. MMWR Morb Mortal Wkly Rep. 2018;67(12):349\u201358.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"416_CR3","unstructured":"West Virginia Department of Health and Human Resources. West Virginia drug overdose deaths historical overview 2001\u20132015 [Internet]. Charleston, WV; 2017 Aug [cited 2018 Aug 21] p. 25. https:\/\/dhhr.wv.gov\/oeps\/disease\/ob\/documents\/opioid\/wv-drug-overdoses-2001_2015.pdf"},{"key":"416_CR4","first-page":"1999","volume-title":"Centers for Disease Control and Prevention","author":"National Center for Health Statistics","year":"2018","unstructured":"National Center for Health Statistics. Centers for Disease Control and Prevention. Multiple causes of death: CDC WONDER Online Database; 2018. p. 1999\u20132017."},{"key":"416_CR5","unstructured":"U.S. Census Bureau QuickFacts: UNITED STATES [Internet]. [cited 2018 Aug 22]. https:\/\/www.census.gov\/quickfacts\/fact\/table\/wv,cabellcountywestvirginia,kanawhacountywestvirginia,huntingtoncitywestvirginia,charlestoncitywestvirginia,US\/PST045217"},{"key":"416_CR6","unstructured":"Benson C, Bishaw A. Poverty: 2017 and 2018. U.S. Department of Commerce, U.S. Census Bureau; 2019 Nov. (American Community Survey Briefs). Report No.: ACSBR\/18-02(RV)."},{"key":"416_CR7","first-page":"15","volume-title":"Appalachian mental health","author":"PD Beaver","year":"1988","unstructured":"Beaver PD. Appalachian cultural systems, past and present. In: Keefe SE, editor. Appalachian mental health. Kentucky: University Press of Kentucky; 1988. p. 15\u201323."},{"issue":"1","key":"416_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1549-0831.2009.00004.x","volume":"75","author":"SE Bell","year":"2010","unstructured":"Bell SE, York R. Community economic identity: the coal industry and ideology construction in West Virginia. Rural Sociol. 2010;75(1):111\u201343.","journal-title":"Rural Sociol"},{"key":"416_CR9","unstructured":"Spence B, Kunkel C, Schewel E, Boettner T, Martin L. Who owns West Virginia? West Virginia Center on Budget & Policy. 2013;13."},{"key":"416_CR10","unstructured":"Parker L. A century of controversy, accidents in West Virginia\u2019s chemical valley in lead-up to spill. National Geographic. 2014;"},{"issue":"2","key":"416_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1086026699122002","volume":"12","author":"J Fox","year":"1999","unstructured":"Fox J. Mountaintop removal in West Virginia: an environmental sacrifice zone. Organ Environ. 1999;12(2):163\u201383.","journal-title":"Organ Environ"},{"issue":"4","key":"416_CR12","first-page":"8","volume":"3","author":"CA Coyne","year":"2006","unstructured":"Coyne CA, Demian-Popescu C, Friend D. Social and cultural factors influencing health in Southern West Virginia: a qualitative study. Prev Chronic Dis. 2006;3(4):8.","journal-title":"Prev Chronic Dis"},{"key":"416_CR13","unstructured":"West Virginia Civic Health Index [Internet]. National Conference on Citizenship. [cited 2019 Aug 12]. https:\/\/ncoc.org\/research-type\/west-virginia-civic-health-index\/"},{"key":"416_CR14","unstructured":"50 Most Generous Cities in America [Internet]. Barna Group. 2016 [cited 2019 Aug 12]. https:\/\/www.barna.com\/research\/50-most-generous-cities-in-america\/"},{"issue":"2","key":"416_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","volume":"25","author":"SG Mars","year":"2014","unstructured":"Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. \u201cEvery \u2018never\u2019 I ever said came true\u201d: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257\u201366.","journal-title":"Int J Drug Policy"},{"key":"416_CR16","unstructured":"Centers for Disease Control and Prevention. U.S. County Prescribing Rates, 2016 [Internet]. U.S. County Prescribing Rates, 2016 | Drug Overdose | CDC Injury Center. 2017 [cited 2018 Aug 22]. https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxcounty2016.html"},{"issue":"3","key":"416_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1360-0443.2011.03635.x","volume":"107","author":"AM Young","year":"2012","unstructured":"Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2012;107(3):587\u201396.","journal-title":"Addiction"},{"issue":"1\u20132","key":"416_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2010.11.003","volume":"115","author":"JR Havens","year":"2011","unstructured":"Havens JR, Oser CB, Knudsen HK, Lofwall M, Stoops WW, Walsh SL, et al. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend. 2011;115(1\u20132):107\u201312.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"416_CR19","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.2105\/AJPH.2012.300874","volume":"103","author":"JR Havens","year":"2013","unstructured":"Havens JR, Lofwall MR, Frost SD, Oser CB, Leukefeld CG, Crosby RA. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health. 2013;103(1):e44\u2013e52.","journal-title":"Am J Public Health"},{"issue":"2","key":"416_CR20","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.2105\/AJPH.2013.301709","volume":"104","author":"KM Keyes","year":"2014","unstructured":"Keyes KM, Cerd\u00e1 M, Brady JE, Havens JR, Galea S. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104(2):e52\u2013e5959.","journal-title":"Am J Public Health"},{"issue":"2","key":"416_CR21","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.japh.2016.09.006","volume":"57","author":"C Babcock","year":"2017","unstructured":"Babcock C, Rockich-Winston N, Booth C. Bringing naloxone to ground zero: Huntington, West Virginia. J Am Pharm Assoc. 2017;57(2):S9\u201310.","journal-title":"J Am Pharm Assoc"},{"issue":"76","key":"416_CR22","doi-asserted-by":"publisher","first-page":"102642","DOI":"10.1016\/j.drugpo.2019.102642","volume":"1","author":"KE Schneider","year":"2020","unstructured":"Schneider KE, O\u2019Rourke A, White RH, Park JN, Musci RJ, Kilkenny ME, et al. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone. Int J Drug Policy. 2020;1(76):102642.","journal-title":"Int J Drug Policy"},{"issue":"18","key":"416_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.15585\/mmwr.mm6718a5","volume":"67","author":"D Bixler","year":"2018","unstructured":"Bixler D, Corby-Lee G, Proescholdbell S, Ramirez T, Kilkenny ME, LaRocco M, et al. Access to syringe services programs-Kentucky, North Carolina, and West Virginia, 2013\u20132017. MMWR Morb Mortal Wkly Rep. 2018;67(18):529\u201332.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"416_CR24","unstructured":"W.-O.W.V.H.D. HIV Cluster Identified in Ohio County [Internet]. 2018 [cited 2019 Mar 14]. https:\/\/www.ohiocountyhealth.com\/news\/hiv-cluster-identified-in-ohio-county\/"},{"key":"416_CR25","unstructured":"West Virginia Department of Health and Human Resources Bureau for Public Health. Outbreak of human immunodeficiency virus (HIV) linked to injection drug use. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS). 2019."},{"key":"416_CR26","unstructured":"Office of Epidemiology & Prevention Services. Outbreak of Human Immunodeficiency Virus (HIV) Linked to Injection Drug Use [Internet]. 2020 [cited 2020 Apr 17]. https:\/\/oeps.wv.gov\/hiv-aids\/pages\/default.aspx"},{"issue":"3","key":"416_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193\u2013201.","journal-title":"Int J Drug Policy"},{"key":"416_CR28","doi-asserted-by":"publisher","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduction Journal [Internet]. 2018 Dec [cited 2018 Jul 6];15(1). https:\/\/harmreductionjournal.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12954-018-0232-z","DOI":"10.1186\/s12954-018-0232-z"},{"key":"416_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users\u2019 perceptions of fentanyl-adulterated and-substituted \u2018heroin\u2019. Int J Drug Policy. 2017;46:146\u201355.","journal-title":"Int J Drug Policy"},{"key":"416_CR30","first-page":"1","volume":"50","author":"SG Mars","year":"2017","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD. J Psychoactive Drugs. 2017;50:1\u201310.","journal-title":"J Psychoactive Drugs"},{"key":"416_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107\u201311.","journal-title":"Int J Drug Policy"},{"key":"416_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugpo.2018.08.004","volume":"60","author":"C McKnight","year":"2018","unstructured":"McKnight C, Des Jarlais DC. Being \u201chooked up\u201d during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82\u20138.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"416_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","volume":"108","author":"N Dasgupta","year":"2018","unstructured":"Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182\u20136.","journal-title":"Am J Public Health"},{"key":"416_CR34","unstructured":"Meit M, Heffernan M, Tanenbaum E, Hoffmann T. Appalachian diseases of despair [Internet]. The Walsh Center for Rural Health Analysis; 2017 Aug [cited 2018 Aug 31]. https:\/\/www.arc.gov\/assets\/research_reports\/AppalachianDiseasesofDespairAugust2017.pdf"},{"issue":"2","key":"416_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85\u201394.","journal-title":"Int J Drug Policy"},{"issue":"14","key":"416_CR36","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1081\/JA-120025125","volume":"38","author":"D Ciccarone","year":"2003","unstructured":"Ciccarone D, Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse. 2003;38(14):2049\u201363.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"416_CR37","first-page":"323","volume":"73","author":"MM Van Handel","year":"2016","unstructured":"Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. JAIDS. 2016;73(3):323\u201331.","journal-title":"JAIDS"},{"key":"416_CR38","doi-asserted-by":"publisher","DOI":"10.1525\/9780520943315","volume-title":"Righteous dopefiend","author":"P Bourgois","year":"2009","unstructured":"Bourgois P, Schonberg J. Righteous dopefiend. Berkeleya: University of California Press; 2009."},{"key":"416_CR39","unstructured":"Fessel JN, Mars S, Bourgois P, Ciccarone D. Into the epistemic void: using rapid assessment to investigate the opioid crisis. In: Shukla MB a. RK, editor. Inside ethnography: researchers reflect on the challenges of reaching hidden populations. Berkeley: University of California Press; Forthcoming."},{"key":"416_CR40","unstructured":"Castillo T, Ciccarone D, Davidson PJ, Davis C, Beletsky L, LaRocco M, et al. Reviews of the 2018 WVDHHR-BPH Report of the Kanawha-Charleston Health Department Harm Reduction Syringe Services Program. Distributed to the Kanawha-Charleston Board of Health; 2018."},{"issue":"7","key":"416_CR41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","volume":"71","author":"TJ Cicero","year":"2014","unstructured":"Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71(7):821\u20136.","journal-title":"JAMA Psychiatry"},{"key":"416_CR42","unstructured":"Wootson Jr. CR. One politician\u2019s solution to the overdose problem: Let addicts die. Washington Post [Internet]. 2017 Jun 30 [cited 2019 Aug 13]. https:\/\/www.washingtonpost.com\/news\/to-your-health\/wp\/2017\/06\/28\/a-council-members-solution-to-his-ohio-towns-overdose-problem-let-addicts-die\/"},{"key":"416_CR43","doi-asserted-by":"crossref","unstructured":"Beletsky L. America\u2019s Favorite Antidote: Drug-Induced Homicide in the Age of the Overdose Crisis. SSRN Journal [Internet]. 2018 [cited 2019 Aug 12]. https:\/\/www.ssrn.com\/abstract=3185180","DOI":"10.2139\/ssrn.3185180"},{"key":"416_CR44","first-page":"25","volume-title":"They shared drugs","author":"R Goldensohn","year":"2018","unstructured":"Goldensohn R. They shared drugs. New York: Someone died. Does that make them killers. The New York Times; 2018. p. 25."},{"key":"416_CR45","unstructured":"LaSalle L. An overdose death is not murder: why drug-induced homicide laws are counterproductive and inhumane. The Drug Policy Alliance. 2017;"},{"key":"416_CR46","unstructured":"Interview with Dr. Michael Brumage. 2018."},{"key":"416_CR47","volume-title":"Harm reduction syringe services program: program procedure manual","author":"Kanawha-Charleston Health Department","year":"2017","unstructured":"Kanawha-Charleston Health Department. Harm reduction syringe services program: program procedure manual. Charleston, WV: Kanawha-Charleston Health Department; 2017."},{"issue":"1","key":"416_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-019-0305-7","volume":"16","author":"ST Allen","year":"2019","unstructured":"Allen ST, Grieb SM, O\u2019Rourke A, Yoder R, Planchet E, White RH, et al. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):33.","journal-title":"Harm Reduct J"},{"key":"416_CR49","doi-asserted-by":"publisher","first-page":"257","DOI":"10.15585\/mmwr.mm6708a6","volume":"67","author":"ME Evans","year":"2018","unstructured":"Evans ME, Labuda SM, Hogan V, Agnew-Brune C, Armstrong J, Karuppiah ABP, et al. Notes from the field: HIV infection investigation in a rural Area-West Virginia, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:257\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"416_CR50","first-page":"1307","volume":"37","author":"AH Kral","year":"2004","unstructured":"Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. JAIDS. 2004;37(2):1307\u201312.","journal-title":"JAIDS"},{"issue":"2","key":"416_CR51","first-page":"1307","volume":"37","author":"A Wodak","year":"2006","unstructured":"Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users? A comprehensive review of the international evidence\u2019, substance use and misuse. Subst Use Misuse. 2006;37(2):1307\u201312.","journal-title":"Subst Use Misuse"},{"issue":"5\u20136","key":"416_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0955-3959(03)00147-6","volume":"14","author":"C Voytek","year":"2003","unstructured":"Voytek C, Sherman SG, Junge B. A matter of convenience: factors influencing secondary syringe exchange in Baltimore, Maryland, USA. Int J Drug Policy. 2003;14(5\u20136):465\u20137.","journal-title":"Int J Drug Policy"},{"key":"416_CR53","unstructured":"Crouch BJ, Gupta R, Haddy L. 2018 Evaluation Report of the Kanawha-Charleston Health Department Harm Reduction Syringe Services Program [Internet]. 2018 p. 62. https:\/\/dhhr.wv.gov\/bph\/Documents\/HarmReductionReports\/2018%2520Evaluation%2520Report%2520KCHD%2520HRSSP%2520May%25202018%252005.11.18.pdf"},{"key":"416_CR54","first-page":"27","volume-title":"Why a city at the center of the opioid crisis gave up a tool to fight it","author":"J Katz","year":"2018","unstructured":"Katz J. Why a city at the center of the opioid crisis gave up a tool to fight it. New York Times: New York; 2018. p. 27."},{"key":"416_CR55","first-page":"9","volume":"18","author":"S Murphy","year":"1991","unstructured":"Murphy S, Waldorf D. Kickin\u2019down to the street doc: shooting galleries in the San Francisco Bay Area. Contemp Drug Probs. 1991;18:9.","journal-title":"Contemp Drug Probs"},{"issue":"1","key":"416_CR56","doi-asserted-by":"publisher","first-page":"e0228084","DOI":"10.1371\/journal.pone.0228084","volume":"15","author":"EN Satinsky","year":"2020","unstructured":"Satinsky EN, Doran K, Felton JW, Kleinman M, Dean D, Magidson JF. Adapting a peer recovery coach-delivered behavioral activation intervention for problematic substance use in a medically underserved community in Baltimore City. PLoS ONE. 2020;15(1):e0228084.","journal-title":"PLoS ONE"},{"issue":"6","key":"416_CR57","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1016\/j.jemermed.2012.11.090","volume":"44","author":"P Torka","year":"2013","unstructured":"Torka P, Gill S. Cotton fever: an evanescent process mimicking sepsis in an intravenous drug abuser. J Emerg Med. 2013;44(6):e385\u2013e387387.","journal-title":"J Emerg Med"},{"key":"416_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugpo.2016.02.028","volume":"33","author":"D Ciccarone","year":"2016","unstructured":"Ciccarone D, Bourgois P. Injecting drugs in tight spaces: HIV, cocaine and collinearity in the Downtown Eastside, Vancouver, Canada. Int J Drug Policy. 2016;33:36\u2013433.","journal-title":"Int J Drug Policy"},{"key":"416_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0355-x","volume":"17","author":"M Harris","year":"2020","unstructured":"Harris M, Scott J, Hope V, Wright T, McGowan C, Ciccarone D. Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London. Harm Reduct J. 2020;17:1\u201311.","journal-title":"Harm Reduct J"},{"key":"416_CR60","volume-title":"The spirit level: why greater equality makes societies stronger","author":"RG Wilkinson","year":"2011","unstructured":"Wilkinson RG, Pickett K. The spirit level: why greater equality makes societies stronger. New York: Bloomsbury Press; 2011."},{"key":"416_CR61","unstructured":"US Bureau of the Census. Current Population Survey. Annual Social and Economic Supplements [Internet]. 2019. https:\/\/www2.census.gov\/programs-surveys\/cps\/techdocs\/cpsmar19.pdf"},{"issue":"1","key":"416_CR62","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1353\/eca.2017.0005","volume":"2017","author":"A Case","year":"2017","unstructured":"Case A, Deaton A. Mortality and morbidity in the 21st century. Brookings papers on economic activity. 2017;2017(1):397\u2013476.","journal-title":"Brookings papers on economic activity"},{"key":"416_CR63","unstructured":"Meit M, Heffernan M, Tanenbaum E, Hoffmann T. Appalachian diseases of despair. Appalachian Regional Commission; 2017."},{"key":"416_CR64","unstructured":"Drug Enforcement Administration. DEA 360 Strategy Reach and Impact Report: Charleston. Department of Justice; 2018."},{"issue":"8","key":"416_CR65","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.ssci.2007.06.025","volume":"46","author":"GS Poplin","year":"2008","unstructured":"Poplin GS, Miller HB, Ranger-Moore J, Bofinger CM, Kurzius-Spencer M, Harris RB, et al. International evaluation of injury rates in coal mining: a comparison of risk and compliance-based regulatory approaches. Saf Sci. 2008;46(8):1196\u2013204.","journal-title":"Saf Sci"},{"issue":"6083","key":"416_CR66","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1126\/science.1215191","volume":"336","author":"DI Levine","year":"2012","unstructured":"Levine DI, Toffel MW, Johnson MS. Randomized government safety inspections reduce worker injuries with no detectable job loss. Science. 2012;336(6083):907\u201311.","journal-title":"Science"},{"issue":"7080","key":"416_CR67","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/bmj.314.7080.558","volume":"314","author":"H Bosma","year":"1997","unstructured":"Bosma H, Marmot MG, Hemingway H, Nicholson AC, Brunner E, Stansfeld SA. Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. BMJ. 1997;314(7080):558.","journal-title":"BMJ"},{"key":"416_CR68","unstructured":"Conyon MJ, Richard B. Shared Modes of Compensation and Firm Performance: UK Evidence. NBER Working Paper. 8448."},{"key":"416_CR69","unstructured":"Centers for Disease Control and Prevention: National Center for Health Statistics. 12 Month-ending Provisional Number of Drug Overdose Deaths by Drug or Drug Class [Internet]. 2020 [cited 2020 Jan 30]. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"416_CR70","unstructured":"What to Know About Daniel Prude\u2019s Death. The New York Times [Internet]. 2020 Sep 4 [cited 2020 Sep 11]. https:\/\/www.nytimes.com\/2020\/09\/04\/nyregion\/rochester-daniel-prude.html"},{"key":"416_CR71","unstructured":"Associated Press in Lafayette Louisiana. Louisiana shooting: police killing of Black man sparks outrage and protests. the Guardian [Internet]. 2020 Aug 23 [cited 2020 Sep 11]. https:\/\/www.theguardian.com\/us-news\/2020\/aug\/23\/louisiana-shooting-police-kill-black-man-trayford-pellerin"},{"issue":"2","key":"416_CR72","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/maq.12449","volume":"33","author":"S Mendoza","year":"2019","unstructured":"Mendoza S, Rivera AS, Hansen HB. Re-racialization of addiction and the redistribution of blame in the white opioid epidemic. Med Anthropol Q. 2019;33(2):242\u201362.","journal-title":"Med Anthropol Q"},{"key":"416_CR73","first-page":"213","volume":"2013","author":"W Garriott","year":"2013","unstructured":"Garriott W. You can always tell who\u2019s using meth\": Methamphetamine addiction and the semiotics of criminal difference. Addict Traj. 2013;2013:213\u201337.","journal-title":"Addict Traj"},{"key":"416_CR74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"416_CR75","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","volume":"102","author":"E Wood","year":"2007","unstructured":"Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007;102(6):916\u20139.","journal-title":"Addiction"},{"issue":"7","key":"416_CR76","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1503\/cmaj.1040774","volume":"171","author":"E Wood","year":"2004","unstructured":"Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004;171(7):731\u20134.","journal-title":"CMAJ"},{"issue":"3","key":"416_CR77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.drugpo.2011.03.003","volume":"22","author":"SD Pinkerton","year":"2011","unstructured":"Pinkerton SD. How many HIV infections are prevented by Vancouver Canada\u2019s supervised injection facility? Int J Drug Policy. 2011;22(3):179\u201383.","journal-title":"Int J Drug Policy"},{"key":"416_CR78","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.socscimed.2019.02.014","volume":"225","author":"MC Kennedy","year":"2019","unstructured":"Kennedy MC, Boyd J, Mayer S, Collins A, Kerr T, McNeil R. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver. Can Soc Sci Med. 2019;225:60\u20138.","journal-title":"Can Soc Sci Med"},{"issue":"4","key":"416_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00005217-200611000-00003","volume":"23","author":"F McHolm","year":"2006","unstructured":"McHolm F. Rx for compassion fatigue. J Christ Nurs. 2006;23(4):12\u20139.","journal-title":"J Christ Nurs"},{"key":"416_CR80","doi-asserted-by":"crossref","unstructured":"Medland J, Howard-Ruben J, Whitaker E. Fostering psychosocial wellness in oncology nurses: addressing burnout and social support in the workplace. In: Oncology nursing forum. 2004.","DOI":"10.1188\/04.ONF.47-54"},{"issue":"4","key":"416_CR81","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0196-0644(05)81844-X","volume":"22","author":"JC Linton","year":"1993","unstructured":"Linton JC, Kommor MJ, Webb CH. Helping the helpers: the development of a critical incident stress management team through university\/community cooperation. Ann Emerg Med. 1993;22(4):663\u20138.","journal-title":"Ann Emerg Med"},{"key":"416_CR82","unstructured":"Interview with Dr. John C. Linton. 2020."},{"key":"416_CR83","volume-title":"Opioid response plan for the state of West Virginia","author":"R Gupta","year":"2018","unstructured":"Gupta R. Opioid response plan for the state of West Virginia. Charleston: West Virginia Department of Health and Human Resources; 2018."}],"updated-by":[{"DOI":"10.1186\/s12954-021-00542-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000}}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00416-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-020-00416-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00416-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:04:36Z","timestamp":1778493876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-020-00416-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1186\/s12954-020-00416-w","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12954-021-00542-z","URL":"https:\/\/doi.org\/10.1186\/s12954-021-00542-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for the study protocol was given by the University of California, San Francisco Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was given by all study participants. Consent for publication of their anonymized data was given by all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}